Covariate balance in a Bayesian propensity score analysis of beta blocker therapy in heart failure patients

نویسندگان

  • Lawrence C McCandless
  • Paul Gustafson
  • Peter C Austin
  • Adrian R Levy
چکیده

Regression adjustment for the propensity score is a statistical method that reduces confounding from measured variables in observational data. A Bayesian propensity score analysis extends this idea by using simultaneous estimation of the propensity scores and the treatment effect. In this article, we conduct an empirical investigation of the performance of Bayesian propensity scores in the context of an observational study of the effectiveness of beta-blocker therapy in heart failure patients. We study the balancing properties of the estimated propensity scores. Traditional Frequentist propensity scores focus attention on balancing covariates that are strongly associated with treatment. In contrast, we demonstrate that Bayesian propensity scores can be used to balance the association between covariates and the outcome. This balancing property has the effect of reducing confounding bias because it reduces the degree to which covariates are outcome risk factors.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Beta-blocker use at discharge in patients hospitalized for heart failure is associated with improved survival.

BACKGROUND Previous studies demonstrated that beta-blocker use at the time of hospital discharge significantly increased postdischarge treatment rates, associated with an early (60- to 90-day) survival benefit in patients with heart failure (HF). However, it is unknown whether this therapeutic approach can also improve the long-term survival. We thus examined the long-term effects of beta-block...

متن کامل

Antipsychotic use among nursing home residents.

in the contemporary era, in a trial of 45 852 patients with acute MI, neither a composite outcome of death, reinfarction, or cardiac arrest nor death was significantly reduced by metoprolol compared with placebo. More recent trials suggest that long-term -blocker use is not a necessity for patients without heart failure. While it is true that many patients were excluded from the propensity scor...

متن کامل

Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

OBJECTIVES This study sought to investigate the association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) after primary percutaneous coronary intervention (PCI). BACKGROUND Limited data are available on the efficacy of beta-blocker therapy for secondary prevention in STEMI patients. METHODS Between November 1,...

متن کامل

Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport Trials.

The effects of beta blocker therapy in the settings of heart failure and coronary artery disease have been well described, although little data exist in patients presenting with acute coronary syndromes undergoing percutaneous coronary intervention. The current study will attempt to evaluate the efficacy of beta blocker therapy in this setting. Pooled data from five randomized, controlled trial...

متن کامل

Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients.

OBJECTIVES We sought to investigate the effect of beta-blocker (BB) therapy on survival in patients with severe aortic regurgitation (AR). BACKGROUND Beta-blockers are thought to be contraindicated in patients with AR because a slower heart rate increases the duration of diastole during which AR occurs. But AR also causes neuroendocrine activation similar to a heart failure state for which BB...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Epidemiologic Perspectives & Innovations : EP+I

دوره 6  شماره 

صفحات  -

تاریخ انتشار 2009